Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 21 - 30 of 595
  • PARP inhibitors can shrink tumors in pancreatic cancer patients with specific mutations

    Using a PARP inhibitor as maintenance therapy could provide a less toxic option for patients. Treatment either shrunk tumors or stopped them from growing in 17 of 19 patients in an interim analysis from a trial at the Abramson Cancer Center.

    FULL STORY AT Penn Medicine News

  • Learning to lead and leading to learn: Penn GSE alumni as senior leaders at Penn

     Five “homgrown” senior leaders at Penn draw upon expertise they acquired in Penn GSE’s Higher Education division to achieve professional success and make an impact on the nation’s higher education landscape.

    FULL STORY AT Graduate School of Education

  • Targeted drug for leukemia tested at Penn Medicine helps patients live longer

    Researchers at the Abramson Cancer Center found that an inhibitor drug that targets a specific mutation in relapsed or refractory acute myeloid leukemia helps patients live almost twice as long as those who receive chemotherapy. 

    FULL STORY AT Penn Medicine News

  • CD40 combination therapy can shrink pancreatic tumors

    A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients. The early findings provide hope that this strategy involving a CD40 antibody, a checkpoint inhibitor, and standard-of-care chemotherapy could be effective treatment.

    FULL STORY AT Penn Medicine News

  • Doctors more likely to prescribe preventive therapy when prompted by EMR extension

    A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.

    FULL STORY AT Penn Medicine News

  • Doctors more likely to prescribe preventive therapy when prompted by EMR extension

    A Penn Medicine study shows technology tied to patient records pushing doctors toward a new therapy was more effective than just peer education.

    FULL STORY AT Penn Medicine News

  • Philosophy of race

    Quayshawn Spencer, Robert S. Blank Presidential Associate Professor of Philosophy, explores the question, “What kind of thing is race?” in his classes and research. (Audio)

    FULL STORY AT Omnia

  • Collective consciousness

    Lorena Levano, a graduate student in the College of Liberal and Professional Studies, uses collective social behavior to address sexual harassment and online grooming.

    FULL STORY AT Omnia

  • A.S.P.E.N. honors Irving

    Penn Nursing’s Sharon Y. Irving has been awarded a Distinguished Nutrition Support Nurse Service Award from the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).

    FULL STORY AT Penn Nursing News

  • Why breaking up Big Tech could do more harm than good

    Wharton's Herbert Hovenkamp discusses the merits of Elizabeth Warren's proposal to break up Big Tech firms like Amazon, Google, and Facebook.

    FULL STORY AT Knowledge@Wharton